The Office of Translational Research funds programs to support new technology development and treatments for neurological
disorders and prepares them for investor funding and corporate partnerships. We provide critical path funding and research
resources for biotechnology companies and university researchers to advance early-stage neurological technologies, devices,
and therapeutic programs to industry adoption (i.e., investor funding and corporate partnerships).
Last updated May 1, 2014